98 related articles for article (PubMed ID: 26849075)
1. Membrane-attached Cytokines Expressed by mRNA Electroporation Act as Potent T-Cell Adjuvants.
Weinstein-Marom H; Pato A; Levin N; Susid K; Itzhaki O; Besser MJ; Peretz T; Margalit A; Lotem M; Gross G
J Immunother; 2016; 39(2):60-70. PubMed ID: 26849075
[TBL] [Abstract][Full Text] [Related]
2. Messenger RNA encoding constitutively active Toll-like receptor 4 enhances effector functions of human T cells.
Pato A; Eisenberg G; Machlenkin A; Margalit A; Cafri G; Frankenburg S; Merims S; Peretz T; Lotem M; Gross G
Clin Exp Immunol; 2015 Nov; 182(2):220-9. PubMed ID: 26212048
[TBL] [Abstract][Full Text] [Related]
3. Combined Expression of Genetic Adjuvants Via mRNA Electroporation Exerts Multiple Immunostimulatory Effects on Antitumor T Cells.
Weinstein-Marom H; Levin N; Pato A; Shmuel N; Sharabi-Nov A; Peretz T; Eisenberg G; Lotem M; Itzhaki O; Besser MJ; Gross G
J Immunother; 2019; 42(2):43-50. PubMed ID: 30489430
[TBL] [Abstract][Full Text] [Related]
4. Potent Activation of Human T Cells by mRNA Encoding Constitutively Active CD40.
Levin N; Weinstein-Marom H; Pato A; Itzhaki O; Besser MJ; Eisenberg G; Peretz T; Lotem M; Gross G
J Immunol; 2018 Nov; 201(10):2959-2968. PubMed ID: 30305327
[TBL] [Abstract][Full Text] [Related]
5. Transfer of mRNA encoding recombinant immunoreceptors reprograms CD4+ and CD8+ T cells for use in the adoptive immunotherapy of cancer.
Birkholz K; Hombach A; Krug C; Reuter S; Kershaw M; Kämpgen E; Schuler G; Abken H; Schaft N; Dörrie J
Gene Ther; 2009 May; 16(5):596-604. PubMed ID: 19158846
[TBL] [Abstract][Full Text] [Related]
6. Modulation of regulatory T cell function by monocyte-derived dendritic cells matured through electroporation with mRNA encoding CD40 ligand, constitutively active TLR4, and CD70.
Pen JJ; De Keersmaecker B; Maenhout SK; Van Nuffel AM; Heirman C; Corthals J; Escors D; Bonehill A; Thielemans K; Breckpot K; Aerts JL
J Immunol; 2013 Aug; 191(4):1976-83. PubMed ID: 23842750
[TBL] [Abstract][Full Text] [Related]
7. Antibodies to TR2 (herpesvirus entry mediator), a new member of the TNF receptor superfamily, block T cell proliferation, expression of activation markers, and production of cytokines.
Harrop JA; Reddy M; Dede K; Brigham-Burke M; Lyn S; Tan KB; Silverman C; Eichman C; DiPrinzio R; Spampanato J; Porter T; Holmes S; Young PR; Truneh A
J Immunol; 1998 Aug; 161(4):1786-94. PubMed ID: 9712045
[TBL] [Abstract][Full Text] [Related]
8. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
[TBL] [Abstract][Full Text] [Related]
9. In vivo depletion of CD4+CD25+ regulatory T cells enhances the antigen-specific primary and memory CTL response elicited by mature mRNA-electroporated dendritic cells.
Van Meirvenne S; Dullaers M; Heirman C; Straetman L; Michiels A; Thielemans K
Mol Ther; 2005 Nov; 12(5):922-32. PubMed ID: 16257383
[TBL] [Abstract][Full Text] [Related]
10. Regulation of 4-1BB expression by cell-cell interactions and the cytokines, interleukin-2 and interleukin-4.
Pollok KE; Kim SH; Kwon BS
Eur J Immunol; 1995 Feb; 25(2):488-94. PubMed ID: 7875212
[TBL] [Abstract][Full Text] [Related]
11. Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy.
Chen HW; Liao CH; Ying C; Chang CJ; Lin CM
Clin Immunol; 2006 Apr; 119(1):21-31. PubMed ID: 16406844
[TBL] [Abstract][Full Text] [Related]
12. Different tumours, transduced with different cytokine genes as G-CSF and IL-2, show inhibition of tumour take through neutrophil activation but differ in T cell functions.
Stoppacciaro A; Forni G; Colombo MP
Folia Biol (Praha); 1994; 40(1-2):89-99. PubMed ID: 7525363
[TBL] [Abstract][Full Text] [Related]
13. Expression of toll-like receptor 4 on dendritic cells is significant for anticancer effect of dendritic cell-based immunotherapy in combination with an active component of OK-432, a streptococcal preparation.
Okamoto M; Furuichi S; Nishioka Y; Oshikawa T; Tano T; Ahmed SU; Takeda K; Akira S; Ryoma Y; Moriya Y; Saito M; Sone S; Sato M
Cancer Res; 2004 Aug; 64(15):5461-70. PubMed ID: 15289356
[TBL] [Abstract][Full Text] [Related]
14. Ex vivo induction of viral antigen-specific CD8 T cell responses using mRNA-electroporated CD40-activated B cells.
Van den Bosch GA; Ponsaerts P; Nijs G; Lenjou M; Vanham G; Van Bockstaele DR; Berneman ZN; Van Tendeloo VF
Clin Exp Immunol; 2005 Mar; 139(3):458-67. PubMed ID: 15730391
[TBL] [Abstract][Full Text] [Related]
15. Participation of pigment epithelium of iris and ciliary body in ocular immune privilege. 1. Inhibition of T-cell activation in vitro by direct cell-to-cell contact.
Yoshida M; Takeuchi M; Streilein JW
Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):811-21. PubMed ID: 10711698
[TBL] [Abstract][Full Text] [Related]
16. Synergistic enhancement of antitumor immunity with adoptively transferred tumor-specific CD4+ and CD8+ T cells and intratumoral lymphotactin transgene expression.
Huang H; Li F; Gordon JR; Xiang J
Cancer Res; 2002 Apr; 62(7):2043-51. PubMed ID: 11929823
[TBL] [Abstract][Full Text] [Related]
17. LPS stimulates and Hsp70 down-regulates TLR4 to orchestrate differential cytokine response of culture-differentiated innate memory CD8(+) T cells.
Ghosh AK; Sinha D; Mukherjee S; Biswas R; Biswas T
Cytokine; 2015 May; 73(1):44-52. PubMed ID: 25697138
[TBL] [Abstract][Full Text] [Related]
18. Adoptive immunotherapy with tumor-specific T lymphocytes generated from cytokine gene-modified tumor-primed lymph node cells.
Ohno K; Yoshizawa H; Tsukada H; Takeda T; Yamaguchi Y; Ichikawa K; Maruyama Y; Suzuki Y; Suzuki E; Arakawa M
J Immunol; 1996 May; 156(10):3875-81. PubMed ID: 8621926
[TBL] [Abstract][Full Text] [Related]
19. Single-step antigen loading and activation of dendritic cells by mRNA electroporation for the purpose of therapeutic vaccination in melanoma patients.
Bonehill A; Van Nuffel AM; Corthals J; Tuyaerts S; Heirman C; François V; Colau D; van der Bruggen P; Neyns B; Thielemans K
Clin Cancer Res; 2009 May; 15(10):3366-75. PubMed ID: 19417017
[TBL] [Abstract][Full Text] [Related]
20. Expression and costimulatory effects of the TNF receptor superfamily members CD134 (OX40) and CD137 (4-1BB), and their role in the generation of anti-tumor immune responses.
Taraban VY; Rowley TF; O'Brien L; Chan HT; Haswell LE; Green MH; Tutt AL; Glennie MJ; Al-Shamkhani A
Eur J Immunol; 2002 Dec; 32(12):3617-27. PubMed ID: 12516549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
